Abstract Interleukin-6 (IL-6) is a multi-tasking cytokine that represents high activity in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and cancer. High …
F Zhao, Q Ma, Q Yue, H Chen - Clinical microbiology reviews, 2022 - Am Soc Microbiol
The lung is the primary site of severe acute respiratory syndrome coronavirus 2 (SARS-CoV- 2)-induced immunopathology whereby the virus enters the host cells by binding to …
Classification of pneumonia in animals has been controversial, and the most problematic pattern is interstitial pneumonia. This is true from the gross and histologic perspectives, and …
LG Wang, L Wang - ImmunoTargets and Therapy, 2022 - Taylor & Francis
Since the beginning of the SARS-CoV-2 pandemic, the treatments and management of the deadly COVID-19 disease have made great progress. The strategies for developing novel …
Y Xue, H Mei, Y Chen, JD Griffin, Q Liu… - MedComm, 2023 - Wiley Online Library
Abstract The coronavirus disease 2019 (COVID‐19) pandemic has affected a large portion of the global population, both physically and mentally. Current evidence suggests that the …
P Wang, C Wang, D Chen - European Journal of …, 2023 - journals.sagepub.com
Objective To identify whether thymosin-α-1 (Tα1) is effective in patients with Coronavirus disease 2019 (COVID-19) and to determine a suitable population for Tα1 treatment …
SJC Pallett, R Wake, J Youngs, C Pope… - British Journal of …, 2022 - ncbi.nlm.nih.gov
Discussion Determining SARS-CoV-2 viability in patients with haematological malignancy has implications for treatment-based decision-making. For example, B-cell depletion with …
F Aghaeimeybodi, MM Derakhshan Barjoei… - Clinical Case …, 2022 - Wiley Online Library
COVID‐19 showed different characteristics, and many cases showed clinical manifestations that could not be attributed to other conditions. We present a 22‐year‐old woman who had …
TTT Nga, NT Quang, NTT Trang… - Tạp chí Y Dược học …, 2023 - tapchi.ctump.edu.vn
Tóm tắt Vi rút corona gây hội chứng suy hô hấp cấp tính SARS‐CoV‐2, đã xuất hiện vào tháng 12 năm 2019 tại Vũ Hán, Trung Quốc. Vi rút SAR-CoV-2 có thể kích hoạt các phản …